Edgewell Personal Care Company (EPC) Income Statement

The revenue trajectory has been consistently negative over the past ten quarters, with only one quarter of positive growth (2025Q4 at 3.8%). The most recent quarter's 9.1% decline is the steepest, indicating that competitive dynamics and consumer trade-down may be intensifying. While management noted organic growth returning in North America, the absolute figures suggest that the company is still losing share or facing category headwinds. The reliance on private-label manufacturing may provide a floor, but it does not appear to be driving meaningful top-line expansion.

The gross margin profile is structurally lower than peers like Church & Dwight (44.7%), indicating a higher mix of value-tier and private-label products. The recent improvement to 42.5% in 2026Q3 is encouraging, but it remains below the 44.3% peak seen in 2024Q3. This suggests that the company has limited pricing power and is vulnerable to commodity cost swings. The thin operating margin of 4.34% amplifies the impact of any gross margin contraction, leaving little buffer for unexpected cost increases.

SG&A expenses have remained relatively sticky, averaging around $150M per quarter even as revenue declined. This has caused operating margins to fluctuate wildly, from 12.8% in 2024Q3 to -6.8% in 2025Q4. The lack of operating leverage suggests that the cost base is not flexible enough to adapt to lower volumes, possibly due to fixed manufacturing overhead and necessary brand support. The recent quarter's operating margin of 4.4% is a recovery, but it is still far below the levels needed to generate sustainable returns.

The cost structure is heavily weighted towards variable inputs like steel and resins, which have been volatile. The gross margin decline from 44.3% to 42.5% over the period suggests that input cost inflation is not being fully passed through to consumers. SG&A expenses have not declined proportionally with revenue, indicating that the company is maintaining marketing spend to defend market share. The thin net margin of 1.14% leaves little room for error, and any further cost increases could push the company into sustained losses.

This quarter stands out as the operational trough, with revenue down 11.6% year-over-year and a negative operating margin. The subsequent quarters show a recovery, with gross margin rebounding to 42.5% and net income turning positive, suggesting that the Q1 weakness may have been seasonal or related to restructuring charges. However, the recovery is not yet robust, as the latest quarter's net margin of 2.4% is still below the 7.6% seen in 2024Q3. This inflection point highlights the company's vulnerability to seasonal and external shocks, and investors should monitor whether the recovery can be sustained.